Injection site reactions are the primary complaint
The best treatment is prevention
Vildagliptin: peripheral oedema and nasopharyngitis Interactions Clinically significant drug interactions are described as follows: *Sitagliptin is metabolised primarily by CYP3A4, in severe renal impairment metabolism plays a more significant role in sitagliptin elimination, therefore potent CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir, clarithromycin) may increase sitagliptin plasma levels in severe renal impairment The blood glucose-lowering effects of DPP-4 inhibitors may also be enhanced or inhibited by other substances: References DPP-4 inhibitors | Prescribing information | Diabetes type 2 | CKS | NICE Sitagliptin 100 mg Film-coated Tablets Summary of Product Characteristics (SmPC) (emc) Onglyza 2.5mg film-coated tablets Summary of Product Characteristics (SmPC) (emc) Trajenta 5 mg film-coated tablets Summary of Product Characteristics (SmPC) (emc) Alogliptin 12.5 mg film-coated tablets Summary of Product Characteristics (SmPC) (emc)

More dramatic changes typically appear after several weeks of consistent treatment
Using this product daily makes me feel like I just stepped out of a spa
If you have any additional questions regarding the availability of testing, please contact our laboratory by telephone or email.** Sample Type: Whole Blood Turnaround Time: 2-3 Weeks Performing Laboratory: SpectraCell Micronutrient Test SpectraCells Micronutrient test provides the most comprehensive nutritional analysis available by measuring functional deficiencies at the cellular level